Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation.
about
Role of protein tyrosine phosphatases in cancerSrc homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway.Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy.The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions.Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma.Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.Risk Factors of Follicular Lymphoma.Tumor suppressor gene methylation in follicular lymphoma: a comprehensive reviewGene silencing by DNA methylation in haematological malignancies.Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.Tumor suppressors in follicular lymphoma.Gene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia.Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.Shp1 function in myeloid cells.Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy.Expression of PTEN and SHP1, investigated from tissue microarrays in pediatric acute lymphoblastic, leukemia.Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphomaIncreased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.Epigenetic modifications of DAPK and p16 genes contribute to arsenic-induced skin lesions and nondermatological health effects.SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma.Protein Tyrosine Phosphatases as Potential Regulators of STAT3 SignalingInhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer
P2860
Q28741003-6C56A40F-C8F1-4811-9F66-5E60777B621EQ30424937-A17F41CE-3E40-4BD9-AD83-C912C34C6D0BQ33908446-7D2360F5-FA77-4881-A057-458BB6F7894BQ33913937-1D1D385C-52B4-437D-8B99-7711F46C5B73Q33924261-3F357758-7CFB-4975-B839-6507BAA9F313Q34707404-255CF085-C37F-4888-980B-20A3E7230678Q35934571-A79E3A78-A26F-4207-9678-C36BF422070AQ36062546-22BDBB57-E618-42CB-894F-79667605CA81Q36616696-6DACD5C2-3FE8-4E1B-BBB5-E0783A6285A8Q36816162-7CB6A658-A843-42E0-9BE5-9C5F5219C57BQ37062143-708305EF-A07B-48B8-A7E3-DF3FE68B5E7CQ38266066-739B46F6-45D6-4996-8229-15824E1CAAD1Q38435146-282EB1CC-813E-4FEF-8AEA-19CEA2EAEA1AQ38659065-1667F1BA-1C1B-4EFD-B4A2-AC6BCBE5B7F2Q38824324-C9F7ED68-8557-4A75-BF16-15DA06D3BF73Q39025707-E002FBE8-FC88-4DE8-8E0D-81FA66C2BBA1Q39367824-052078AB-7695-4187-A156-7A7048C12E82Q39996936-1563C7C4-26B2-4EB6-94E3-C7CDCA04C8A7Q40003836-4C614EB3-6AFA-4F5E-AC3C-B721FEB6F3EFQ41786430-DEFF5001-DD20-40E0-8E89-19DC8F7ABA31Q42000292-EE19BD9B-018D-40A1-B9AD-5A42D1014DCCQ42710197-A71353C3-10DE-4AE6-B724-1E6C02DA9496Q48909084-F7DDCC09-EDE7-4921-A6BE-E03D93C6DA55Q51134087-50B32291-5AA8-49BF-ADC0-BFC4098EAE0BQ58749617-8BD9F37A-3952-4B19-AD4C-BE82A53F36E9Q58761778-213AB293-629A-44F7-90BB-77C4BADDB471
P2860
Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Activated proliferation of B-c ...... g by aberrant CpG methylation.
@en
type
label
Activated proliferation of B-c ...... g by aberrant CpG methylation.
@en
prefLabel
Activated proliferation of B-c ...... g by aberrant CpG methylation.
@en
P2093
P2860
P1476
Activated proliferation of B-c ...... g by aberrant CpG methylation.
@en
P2093
Kazuhiko Hayashi
Maho Koyama
Mamoru Ouchida
Ritsuo Nishiuchi
Tadaatsu Akagi
Tadashi Yoshino
Takashi Oka
Yoko Nakatani
Yoshiki Seino
P2860
P304
P356
10.1097/01.LAB.0000106503.65258.2B
P577
2003-12-01T00:00:00Z
P6179
1012557211